X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (246) 246
Patent (24) 24
Conference Proceeding (19) 19
Publication (11) 11
Dissertation (8) 8
Book Chapter (6) 6
Book / eBook (3) 3
Book Review (2) 2
Newspaper Article (2) 2
Video Recording (2) 2
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (107) 107
female (81) 81
male (81) 81
index medicus (79) 79
adult (69) 69
middle aged (68) 68
infectious medicine (48) 48
infektionsmedicin (48) 48
infectious diseases (43) 43
medical and health sciences (43) 43
medicin och hälsovetenskap (43) 43
hepatitis c (36) 36
treatment outcome (34) 34
genotype (32) 32
aged (31) 31
hepacivirus - genetics (30) 30
virology (30) 30
clinical medicine (29) 29
klinisk medicin (29) 29
gastroenterology & hepatology (28) 28
ribavirin (28) 28
hepatitis c, chronic - drug therapy (26) 26
hepatitis c virus (25) 25
infection (25) 25
microbiology in the medical area (25) 25
mikrobiologi inom det medicinska området (25) 25
rna (22) 22
antiviral agents - therapeutic use (20) 20
drug therapy (20) 20
interferon (19) 19
medicine (19) 19
plus ribavirin (19) 19
viral load (19) 19
antiviral agents - administration & dosage (18) 18
health aspects (18) 18
young adult (18) 18
fibrosis (17) 17
hepatitis (17) 17
interferon-alpha - therapeutic use (17) 17
research article (17) 17
ribavirin - therapeutic use (17) 17
therapy (17) 17
time factors (17) 17
viruses (17) 17
adolescent (16) 16
diagnosis (16) 16
genetics (16) 16
interferon-alpha - administration & dosage (16) 16
pcr (16) 16
prognosis (16) 16
recombinant proteins (16) 16
ribavirin - administration & dosage (16) 16
aged, 80 and over (15) 15
drug therapy, combination (15) 15
hepatitis c, chronic - virology (15) 15
rna, viral - blood (15) 15
children (14) 14
genetic aspects (14) 14
microbiology (14) 14
gastroenterology and hepatology (13) 13
hepacivirus (13) 13
polyethylene glycols - administration & dosage (13) 13
prospective studies (13) 13
sweden (13) 13
biopsy (12) 12
mechanical engineering (12) 12
polyethylene glycols - therapeutic use (12) 12
risk factors (12) 12
virus diseases (12) 12
analysis (11) 11
antiviral agents (11) 11
care and treatment (11) 11
combination (11) 11
hematology (11) 11
hepacivirus - drug effects (11) 11
interferon-alpha (11) 11
liver - pathology (11) 11
transplantation (11) 11
blasting (10) 10
chronic (10) 10
cirrhosis (10) 10
heating (10) 10
hepatitis c - drug therapy (10) 10
hepatitis c, chronic - pathology (10) 10
hospitals (10) 10
kinetics (10) 10
lighting (10) 10
liver (10) 10
medical research (10) 10
peginterferon alpha-2a (10) 10
retrospective studies (10) 10
science (10) 10
sweden - epidemiology (10) 10
weapons (10) 10
administration & dosage (9) 9
genetic-variation (9) 9
genotypes (9) 9
infections (9) 9
interleukins - genetics (9) 9
liver cirrhosis - pathology (9) 9
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (296) 296
Swedish (11) 11
French (10) 10
German (8) 8
Spanish (2) 2
Chinese (1) 1
Finnish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Brain Mapping, ISSN 1065-9471, 06/2019, Volume 40, Issue 8, pp. 2529 - 2545
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1019 - 1026
Summary Background Present first-line therapy for diffuse large B-cell lymphoma, a subtype of non-Hodgkin lymphoma, is rituximab, cyclophosphamide,... 
Hematology, Oncology and Palliative Medicine | THERAPY | OLDER PATIENTS | ONCOLOGY | FEBRILE NEUTROPENIA | PCI-32765 | CHRONIC LYMPHOCYTIC-LEUKEMIA | CLASSIFICATION | RANDOMIZED CONTROLLED-TRIAL | TARGETING BTK | ELDERLY-PATIENTS | CHEMOTHERAPY | Doxorubicin - therapeutic use | Pyrazoles - therapeutic use | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Non-Randomized Controlled Trials as Topic | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Pyrazoles - adverse effects | Severity of Illness Index | Antigens, CD20 - immunology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Rituximab | Survival Rate | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Antigens, CD20 - drug effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphoma, Non-Hodgkin - diagnosis | Care and treatment | Anthracyclines | Cyclophosphamide | Prednisone | Corticosteroids | Tumors
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 05/2019, Volume 62, Issue 9, pp. 4325 - 4349
5-Lipoxygenase (5-LO)-activating protein (FLAP) inhibitors have proven to attenuate 5-LO pathway activity and leukotriene production in human clinical trials.... 
CHEMISTRY, MEDICINAL | SINGLE | ACID | PHARMACOKINETICS | HUMANS | AM803 | PHARMACODYNAMICS | FLAP INHIBITOR | DISCOVERY
Journal Article
BMC Public Health, ISSN 1471-2458, 2011, Volume 11, Issue 1, pp. 718 - 718
Background: Welfare dependence and low work participation among young people have raised concern in many European countries. Reading and writing difficulties... 
YOUNG-ADULTS | SCHOOL | POPULATION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | BEHAVIOR PROBLEMS | DYSLEXIA | DISABILITY PENSION | SICKNESS ABSENCE | DISORDERS | CHILDREN | COMORBIDITY | Reading | Social Welfare | Follow-Up Studies | Risk Assessment | Employment | Norway | Humans | Adolescent | Writing | Female | Male | Health Status | Psychological aspects | Performance standards | Adolescence | Case management (Social services) | Usage | Research
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 973 - 982
Summary Background Compared with placebo, prophylactic treatment with bisphosphonates reduces risk of skeletal events in patients with multiple myeloma.... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | BISPHOSPHONATES | MULTICENTER | EFFICACY | ONCOLOGY | CLODRONATE | QUALITY-OF-LIFE | STEM-CELL TRANSPLANTATION | DKK1 | CHEMOTHERAPY | BONE-RESORPTION | Multiple Myeloma - mortality | Humans | Middle Aged | Male | Transplantation, Autologous | Jaw Diseases - chemically induced | Stem Cell Transplantation | Bone Diseases - etiology | Multiple Myeloma - therapy | Time Factors | Aged, 80 and over | Female | Diphosphonates - adverse effects | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Multiple Myeloma - diagnosis | Risk Assessment | Multiple Myeloma - complications | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Bone Diseases - prevention & control | Treatment Outcome | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Bone Diseases - diagnostic imaging | Scandinavian and Nordic Countries | Radiography | Bone Diseases - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Aged | Infusions, Intravenous | Osteonecrosis - chemically induced | Medicine, Experimental | Clinical trials | Medical research | Care and treatment | Multiple myeloma | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
European Journal of Organic Chemistry, ISSN 1434-193X, 06/2018, Volume 2018, Issue 23, pp. 2995 - 3000
During our investigation to find suitable conditions to prepare very high molecular weight partially de‐acetylated hyaluronic acid (HA), we discovered a... 
Transamidation | Hydroxylamine salts | Hyaluronic acid | pH sensitivity | CALIBRATION | HYDROXAMIC ACIDS | CHEMISTRY, ORGANIC | MECHANISMS | CHROMATOGRAPHY | HYDROXYLAMINOLYSIS | DERMAL FILLERS | SCIENCE | SKIN | Carbamates | Hydrogen-ion concentration
Journal Article
Transportation Research, Part A: Policy and Practice, ISSN 0965-8564, 2018, Volume 117, Issue November, p. 205
In this study a model was applied on consumer acceptance of commonly implemented EV focused measures. The model is based on a norm-activation process as... 
Samhällsvetenskap | Economics and Business | Social Sciences | Företagsekonomi | Ekonomi och näringsliv | Business Administration
Journal Article
Journal of Cleaner Production, ISSN 0959-6526, 06/2017, Volume 154, pp. 176 - 187
Journal Article